Precigen
PGEN
130 hedge funds and large institutions have $89.7M invested in Precigen in 2024 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 34 increasing their positions, 46 reducing their positions, and 15 closing their positions.
707% more call options, than puts
Call options by funds: $541K | Put options by funds: $67K
5% more capital invested
Capital invested by funds: $85.6M → $89.7M (+$4.15M)
0.79% less ownership
Funds ownership: 25.65% → 24.87% (-0.79%)
5% less funds holding
Funds holding: 137 → 130 (-7)
26% less repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 46
33% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 15
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Patient Capital Management
Baltimore,
Maryland
|
+$2.11M |
| 2 |
D.E. Shaw & Co
New York
|
+$1.11M |
| 3 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$1.01M |
| 4 |
CA
Cetera Advisors
Denver,
Colorado
|
+$363K |
| 5 |
Renaissance Technologies
New York
|
+$255K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$2.12M |
| 2 |
Morgan Stanley
New York
|
-$2.1M |
| 3 |
BlackRock
New York
|
-$1.09M |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$500K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$500K |
PGEN Hedge Fund Activity: Q1 2024 in Review
130 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Precigen (PGEN) for Q1 2024, worth a combined $89.7M — up 4.9% from $85.6M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of PGEN and 10 opened new positions — a net loss of 5 holders — while 46 trimmed existing stakes and 34 added.
The largest buyer was Patient Capital Management, adding an estimated $2.11M. The largest seller was Millennium Management, cutting an estimated $2.12M.
- 130 institutional investors held Precigen (PGEN) as of Q1 2024, down from 137 in Q4 2023.
- Funds reported $89.7M of Precigen stock for Q1 2024, up 4.9% quarter-over-quarter.
- 10 funds opened new Precigen positions in Q1 2024 and 15 closed out, a net change of -5 holders.
- The largest Precigen buyer in Q1 2024 was Patient Capital Management, an estimated $2.11M added.
- The largest Precigen seller in Q1 2024 was Millennium Management, an estimated $2.12M sold.
Based on aggregated 13F filings for Q1 2024.